Evidence map›Paper›PMID 29383156›Full record

ArticleOncotarget2017

Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition.

Jian Liu, Xiao Zheng, Haifeng Deng, Bin Xu, Lujun Chen, Qi Wang, Qi Zhou, Dachuan Zhang, Changping Wu, Jingting Jiang

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jian Liu *Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Xiao Zheng *Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Haifeng DengDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Bin XuDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Lujun ChenDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Qi WangDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Qi ZhouDepartment of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Dachuan ZhangDepartment of Pathology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Changping WuDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Jingting JiangDepartment of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) is the most common esophageal cancer associated with poor prognosis. We detected the expression of C-C motif chemokine receptor 6 (CCR6) and epithelial-to-mesenchymal transition (EMT) markers in esophageal tissues/cells, and evaluated the effects of CCR6 on ESCC cells proliferation, migration and invasion in response to C-C motif chemokine ligand 20 (CCL20) treatment. Our data showed CCR6 was highly expressed in ESCC cell lines (ECA-109 and TE-1), whereas kept in a low expression in normal cell lines HEEC (

Indexed as

C-C motif chemokine receptor 6 (CCR6)epithelial-to-mesenchymal transition (EMT)esophageal squamous cell carcinoma (ESCC)lymph node metastasis

Identifiers

PMID29383156
PMCPMC5777768
OpenAlexW2774216820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.